Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-31

Clinical Trial Update: Effect of the Probiotic ES1 and Its Inactivated Form (HT-ES1) Over Symptomatology Asociated With Allergic Rhinitis [NA]

View source ↗

Summary

A completed clinical trial evaluated the probiotic ES1 and its inactivated form HT-ES1 for symptoms of allergic rhinitis. It was sponsored by Fundació Eurecat.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ES1
  • HT-ES1

Snippet

Sponsor: Fundació Eurecat | Conditions: Allergic Rhinitis | NA | Status: COMPLETED